Condensed consolidated statement of profit or lossfor the six months ended 31 March 2021
| Notes | 2021 R’m |
Change % |
20201 R’m |
||
| Continuing operations | |||||
| Revenue | 13 004 | 4.0 | 12 504 | ||
| Operating expenses | (11 655) | (10 698) | |||
| Operating profit | 1 349 | (25.3) | 1 806 | ||
| Fair value gain/(loss) on derivative financial instruments | 38 | (10) | |||
| Gain on derecognition of lease asset and liability | – | 75 | |||
| Impairment of investment | (9) | – | |||
| Loss on disposal of property, plant and equipment | (5) | (2) | |||
| Transaction costs | – | (5) | |||
| Finance income | 23 | 8 | |||
| Finance cost | (357) | (435) | |||
| Share of associates’ and joint ventures’ net profit after tax | 17 | 10 | |||
| Profit before tax | 1 056 | (27.0) | 1 447 | ||
| Tax expense | (297) | (490) | |||
| Profit after tax from continuing operations | 759 | (20.7) | 957 | ||
| Discontinued operation | |||||
| Profit/(loss) from discontinued operation | 1 | 87 | (21) | ||
| Profit after tax | 846 | (9.6) | 936 | ||
| Profit after tax attributable to: | |||||
| Ordinary equity holders of the parent | 812 | 4.0 | 781 | ||
| Non-controlling interest | 34 | 155 | |||
| 846 | (9.6) | 936 | |||
| Earnings per share (cents) | |||||
| From continuing operations | |||||
| Basic | 49.9 | (9.4) | 55.1 | ||
| Diluted | 49.7 | (9.5) | 54.9 | ||
| From continuing and discontinued operations | |||||
| Basic | 55.9 | 4.1 | 53.7 | ||
| Diluted | 55.7 | 4.1 | 53.5 | ||
| 1 | Prior period re-presented. Scanmed S.A. (Scanmed) was disposed of on 26March 2021 and was included under discontinued operation. Refer note 1. |